Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage

general

16

Centers

38

Active Trials

$4.5B

Cancer Funding

Specific Cancer Types(3)

NameCenters
Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v816
Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v813
Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v85

Top Centers for Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage(16)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
—
2
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
—
3
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
—
4
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
—
5
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
—
6
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
—
7
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
—
8
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
—
9
Cleveland Clinic Cancer CenterCleveland, OH
—
10
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
—
11
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
—
12
University of Illinois Cancer CenterChicago, IL
—
13
Boston University Cancer CenterBoston, MA
—
14
Cancer Center at IllinoisUrbana, IL
—
15
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
—
16
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →